The Way that PEGyl-DSPC Liposomal Doxorubicin Particles Penetrate into Solid Tumor Tissue
Background: For enhancement of drug effectiveness and reduction of drug toxicity, liposomal drugs have been studied in laboratories and clinics for decades. Although the results obtained from in vitro are encouraging, but the results from in vivo tests were not satisfactory. The main reasons for thi...
Main Authors: | Xing Qing Pan, Susie Jones, Karen Cox |
---|---|
Format: | Article |
Language: | English |
Published: |
AboutScience Srl
2006-01-01
|
Series: | Drug Target Insights |
Subjects: | |
Online Access: | http://la-press.com/article.php?article_id=158 |
Similar Items
-
The Way that PEGyl-DSPC Liposomal Doxorubicin Particles Penetrate into Solid Tumor Tissue
by: Xing Qing Pan, et al.
Published: (2006-01-01) -
by: Xing Qing Pan, et al.
Published: (2006-01-01) -
Impact of PEGylated Liposomal Doxorubicin and Carboplatin Combination on Glioblastoma
by: Mohsen Ghaferi, et al.
Published: (2022-10-01) -
Place of pegylated liposomal doxorubicin in the therapy of metastatic breast cancer
by: E. V. Artamonova
Published: (2016-09-01) -
EPRI approach on studying deep skin penetration of tretinoin-containing liposomes
by: Stojković Tamara D., et al.
Published: (2023-01-01)